Treace Financial Statements From 2010 to 2024

TMCI Stock  USD 8.56  0.28  3.38%   
Treace Medical financial statements provide useful quarterly and yearly information to potential Treace Medical Concepts investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Treace Medical financial statements helps investors assess Treace Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Treace Medical's valuation are summarized below:
Gross Profit
114.3 M
Profit Margin
(0.30)
Market Capitalization
515.8 M
Enterprise Value Revenue
2.4802
Revenue
202.9 M
We have found one hundred twenty available fundamental trend indicators for Treace Medical Concepts, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of Treace Medical Concepts current fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The Treace Medical's current Market Cap is estimated to increase to about 1.2 B. The Treace Medical's current Enterprise Value is estimated to increase to about 1.3 B

Treace Medical Total Revenue

114.43 Million

Check Treace Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Treace Medical's main balance sheet or income statement drivers, such as Net Interest Income of 202.7 K, Interest Income of 5.6 M or Depreciation And Amortization of 2.8 M, as well as many indicators such as Price To Sales Ratio of 3.94, Dividend Yield of 0.0 or PTB Ratio of 5.34. Treace financial statements analysis is a perfect complement when working with Treace Medical Valuation or Volatility modules.
  
Check out the analysis of Treace Medical Correlation against competitors.

Treace Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets137.1 M251.9 M68.5 M
Slightly volatile
Short and Long Term Debt Total48.1 M70.3 M29.3 M
Slightly volatile
Other Current Liabilities17.8 M31.8 M10.4 M
Slightly volatile
Total Current Liabilities24.7 M45 M13.5 M
Slightly volatile
Total Stockholder Equity144.8 M137.9 M31.3 M
Slightly volatile
Property Plant And Equipment Net33.1 M31.6 MM
Slightly volatile
Accounts Payable6.1 M11.8 M2.8 M
Slightly volatile
Cash12.3 M13 M19.3 M
Slightly volatile
Non Current Assets Total56.2 M53.5 M10 M
Slightly volatile
Long Term Debt40.4 M53 M26.5 M
Slightly volatile
Cash And Short Term Investments74.9 M123.2 M35 M
Slightly volatile
Net Receivables24.4 M38.1 M15.3 M
Slightly volatile
Common Stock Total Equity42.9 K63.2 K34.3 K
Slightly volatile
Common Stock Shares Outstanding60 M60.9 M52.9 M
Slightly volatile
Liabilities And Stockholders Equity137.1 M251.9 M68.5 M
Slightly volatile
Non Current Liabilities Total47.4 M68.9 M29.1 M
Slightly volatile
Inventory16 M29.2 M9.2 M
Slightly volatile
Other Current Assets4.1 M7.9 M1.8 M
Slightly volatile
Other Stockholder Equity285.6 M272 M65.4 M
Slightly volatile
Total Liabilities72.1 M114 M42.6 M
Slightly volatile
Net Invested Capital102.3 M190.9 M46.5 M
Slightly volatile
Property Plant And Equipment Gross42.3 M40.3 M8.2 M
Slightly volatile
Total Current Assets118.6 M198.4 M61 M
Slightly volatile
Capital Stock58.9 K62 K5.9 M
Slightly volatile
Net Working Capital93.9 M153.3 M47.5 M
Slightly volatile
Common Stock48 K62 K34.5 K
Slightly volatile
Property Plant Equipment18.5 M17.6 M4.4 M
Slightly volatile
Current Deferred RevenueM6.8 M7.4 M
Slightly volatile
Short and Long Term Debt1.4 M1.6 M1.8 M
Slightly volatile
Short Term DebtM1.4 M1.6 M
Slightly volatile
Long Term Debt Total45.1 M60.6 M34.1 M
Slightly volatile
Capital Surpluse154.1 M167 M139 M
Slightly volatile
Deferred Long Term Liabilities138.4 K155.7 K169.5 K
Slightly volatile
Other Assets116.8 K131.4 K143.1 K
Slightly volatile
Intangible Assets7.2 M8.1 M8.8 M
Slightly volatile

Treace Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income5.6 M5.4 M870.6 K
Slightly volatile
Depreciation And Amortization2.8 M5.4 M1.6 M
Slightly volatile
Interest Expense3.8 M5.2 M1.9 M
Slightly volatile
Selling General Administrative24.1 M47 M11.6 M
Slightly volatile
Selling And Marketing Expenses80.4 M140.9 M45.2 M
Slightly volatile
Total Revenue114.4 M187.1 M66 M
Slightly volatile
Gross Profit92.3 M151.9 M53.2 M
Slightly volatile
Other Operating Expenses137.6 M238.5 M76.7 M
Slightly volatile
Research Development11 M15.4 M7.1 M
Slightly volatile
Cost Of Revenue22.1 M35.2 M12.8 M
Slightly volatile
Total Operating Expenses115.5 M203.4 M63.9 M
Slightly volatile
Reconciled Depreciation4.7 M4.5 M1.4 M
Slightly volatile
Income Tax Expense3.8 M5.2 M1.9 M
Slightly volatile
Preferred Stock And Other Adjustments156.8 K176.4 K192.1 K
Slightly volatile

Treace Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation18.2 M17.4 M3.7 M
Slightly volatile
Begin Period Cash Flow34.5 M19.5 M13.5 M
Slightly volatile
Other Cashflows From Financing Activities1.8 M1.9 M26.7 M
Slightly volatile
Depreciation5.6 M5.4 M1.5 M
Slightly volatile
Other Non Cash Items2.3 MM923.2 K
Slightly volatile
Capital Expenditures6.9 M11.5 M3.3 M
Slightly volatile
Change To Operating Activities11.3 M10.8 MM
Slightly volatile
Total Cash From Financing Activities59.2 M109.4 M33.7 M
Slightly volatile
End Period Cash Flow12.3 M13 M19.3 M
Slightly volatile
Change To Netincome10.5 M10 M3.1 M
Slightly volatile
Dividends Paid6.3 M7.1 M7.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.944.146425.4612
Slightly volatile
PTB Ratio5.345.6247391
Pretty Stable
Days Sales Outstanding90.1574.247291.1706
Slightly volatile
Book Value Per Share2.382.26680.5395
Slightly volatile
Stock Based Compensation To Revenue0.09740.09270.0337
Slightly volatile
Capex To Depreciation2.472.14092.1114
Slightly volatile
PB Ratio5.345.6247391
Pretty Stable
EV To Sales4.234.452725.6049
Slightly volatile
Inventory Turnover1.611.2031.4159
Slightly volatile
Days Of Inventory On Hand203303258
Slightly volatile
Payables Turnover5.342.97266.8903
Slightly volatile
Sales General And Administrative To Revenue0.140.25130.1377
Slightly volatile
Research And Ddevelopement To Revenue0.110.08250.119
Slightly volatile
Capex To Revenue0.0390.06120.0373
Slightly volatile
Cash Per Share2.132.02450.6869
Slightly volatile
Days Payables Outstanding69.0612360.0969
Slightly volatile
Income Quality1.160.69811.5084
Slightly volatile
Intangibles To Total Assets0.06940.0780.085
Slightly volatile
Current Ratio3.814.40474.1801
Slightly volatile
Tangible Book Value Per Share2.01.90790.4902
Slightly volatile
Receivables Turnover3.624.9164.0199
Slightly volatile
Graham Number6.766.44291.7277
Slightly volatile
Shareholders Equity Per Share2.382.26680.5395
Slightly volatile
Debt To Equity0.370.38436.8452
Very volatile
Capex Per Share0.20.18830.0643
Slightly volatile
Revenue Per Share3.233.0751.2959
Slightly volatile
Interest Debt Per Share0.580.9560.5182
Slightly volatile
Debt To Assets0.20.21040.5442
Slightly volatile
Operating Cycle269378347
Slightly volatile
Price Book Value Ratio5.345.6247391
Pretty Stable
Days Of Payables Outstanding69.0612360.0969
Slightly volatile
Ebt Per Ebit1.930.9631.4366
Pretty Stable
Company Equity Multiplier1.731.826210.372
Very volatile
Long Term Debt To Capitalization0.260.27760.7203
Slightly volatile
Total Debt To Capitalization0.260.27760.7205
Slightly volatile
Debt Equity Ratio0.370.38436.8452
Very volatile
Quick Ratio3.283.75533.4695
Slightly volatile
Net Income Per E B T1.441.271.2494
Slightly volatile
Cash Ratio0.270.28831.6753
Very volatile
Cash Conversion Cycle275255292
Slightly volatile
Days Of Inventory Outstanding203303258
Slightly volatile
Days Of Sales Outstanding90.1574.247291.1706
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.021.33141.1873
Slightly volatile
Price To Book Ratio5.345.6247391
Pretty Stable
Fixed Asset Turnover5.635.928630.8939
Slightly volatile
Debt Ratio0.20.21040.5442
Slightly volatile
Price Sales Ratio3.944.146425.4612
Slightly volatile
Asset Turnover1.10.74281.2028
Slightly volatile
Gross Profit Margin0.640.8120.7944
Slightly volatile
Price Fair Value5.345.6247391
Pretty Stable

Treace Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.2 B775.9 M1.2 B
Slightly volatile
Enterprise Value1.3 B833.2 M1.3 B
Slightly volatile

Treace Fundamental Market Drivers

Cash And Short Term Investments123.2 M

Treace Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Treace Medical Financial Statements

Investors use fundamental indicators, such as Treace Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Treace Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue6.8 MM
Total Revenue187.1 M114.4 M
Cost Of Revenue35.2 M22.1 M
Stock Based Compensation To Revenue 0.09  0.10 
Sales General And Administrative To Revenue 0.25  0.14 
Research And Ddevelopement To Revenue 0.08  0.11 
Capex To Revenue 0.06  0.04 
Revenue Per Share 3.07  3.23 
Ebit Per Revenue(0.27)(0.29)

Currently Active Assets on Macroaxis

When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:
Check out the analysis of Treace Medical Correlation against competitors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
3.274
Quarterly Revenue Growth
0.106
Return On Assets
(0.17)
Return On Equity
(0.51)
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.